Please login to the form below

Not currently logged in

Corporate Responsibility Award


Gilead UK and Ireland Fellowship Programme

Gilead Sciences in association with Wisper Public Affairs

Summary of work

The focus of the 2010 Gilead UK and Ireland Fellowship Programme was to support innovative programmes in HIV and Hepatitis B testing, where currently there is a lack of good practice in local implementation, which is contributing to the rising healthcare costs in the UK.

To date £1.6m in financial support has been provided to 50 projects with pilots implemented across 27 sites. The programme has had a marked impact on clinical outcomes; in 2010, the projects supported by the programme led to 36 new HIV and 103 new Hepatitis B diagnoses. It also provided the first UK specific data to demonstrate the cost-effectiveness of testing in specific settings, which provides critical support to decision makers as they consider the expansion of screening and detection services in line with NICE public health guidance on HIV testing and currently under development in Hepatitis B and C.

The programme has secured significant support from both the HIV and Hepatitis B communities, and there has been a sustained increase in interest in the Fellowship Programme since its inception. This has resulted in a rise in applications for grant support and a measurable increase in screening and detection of HIV and HBV. Key to the programme’s sustained success is the annual Best Practice Sharing Event (BPSE) at which grant recipients gather to share learnings and inform next steps with the specific aim of informing policy. Gilead’s commitment to the programme has been recognised by influential political leaders in the field of healthcare, including Lord Norman Fowler and Baroness Gould.

Judges comments

“Impressive execution and results – the initiative has had a marked impact on clinical outcomes.”  

Stakeholder comments

“56 Dean Street (56DS), Chelsea and Westminster Hospital Foundation Trust’s flagship Sexual Health Service, opened in March 2009 and successfully applied for two projects in the fellowship’s inaugural year. Both of these fellowship-funded projects have been runaway successes with record HIV and Hepatitis B diagnoses. Both projects are thriving and have secured their own funding streams from within the hospital’s HIV & Sexual Health Directorate, the two projects have gone on to win prestigious local and national awards.

‘SORTED’, the HIV testing service at 56DS, is responsible for 1-in-10 of all new HIV diagnoses in London (1-in-5 in gay men) and was runner-up in the British Medical Journal’s Secondary Team of the Year awards in 2010.

The Chinese Hepatitis B service has seen Chronic Hepatitis B rates of 17 per cent (1-in-6 of all patients seen) and won the 2010 regional NHS Health & Social Care award for Partnership Working and was runner-up in the national finals.

The inaugural Best Practice Sharing Event in 2010, was a great opportunity to share experiences (both positive and negative), promote joint learning and show how to deliver improvements in standards of healthcare at minimal cost. We also believe that both projects have helped to alleviate the long-term financial burden on the NHS and ultimately, improve patient care.”
Dr Macky Natha, Consultant HIV/GUM Physician, Chelsea & Westminster Hospital NHS Foundation Trust

Key dates

Entry deadline 26 August 2022
Extended entry deadline 2 September 2022*
*additional fee applies
Judging Day 6 October 2022
Company/Team of the Year Interviews 21 October 2022
PMEA Event 23 November 2022